Sinopharm Group (600511.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 1.476 billion yuan, a year-on-year decrease of 1.07%.

Zhitong Finance APP News, Sinopharm Group (600511.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 40.606 billion yuan, a year-on-year increase of 3.11%; net profit attributable to the parent company was 1.476 billion yuan, a year-on-year decrease of 1.07%; net profit after deducting non-recurring gains and losses was 1.475 billion yuan, a year-on-year increase of 0.36%; basic earnings per share were 1.9566 yuan.